The association of Sort1 expression with LDL subfraction and inflammation in patients with coronary artery disease

References

• Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021;11(2):169–177. doi: 10.2991/jegh.k.201217.001.
   PubMed Web of Science ®Google Scholar
• Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics—2020 update: a report from the American heart association. Circulation. 2020;141(9):e139–e596. doi: 10.1161/CIR.0000000000000757.
   PubMed Web of Science ®Google Scholar
• Aneni EC, Osondu CU, De La Cruz J, et al. Lipoprotein Sub-fractions by ion-mobility analysis and its association with subclinical coronary atherosclerosis in high-risk individuals. J Atheroscler Thromb. 2019; 126(1):50–63. doi: 10.5551/jat.40741.
   PubMed Web of Science ®Google Scholar
• Rizzo M, Berneis K. Small, dense low‐density‐lipoproteins and the metabolic syndrome. Diabetes Metab Res Rev. 2007;23(1):14–20. doi: 10.1002/dmrr.694.
   PubMed Web of Science ®Google Scholar
• Chen Z, Schunkert H. Genetics of coronary artery disease in the post‐GWAS era. J Intern Med. 2021;290(5):980–992. doi: 10.1111/joim.13362.
   PubMed Web of Science ®Google Scholar
• Mitok KA, Keller MP, Attie AD. Sorting through the extensive and confusing roles of sortilin in metabolic disease. J Lipid Res. 2022;63(8):100243. doi: 10.1016/j.jlr.2022.100243.
   PubMed Web of Science ®Google Scholar
• Christoffersen M, Tybjærg-Hansen A. Novel genes in LDL metabolism–a comprehensive overview. Curr Opin Lipidol. 2015;26(3):179–187. doi: 10.1097/MOL.0000000000000175.
   PubMed Web of Science ®Google Scholar
• Willer CJ, Schmidt EM, Sengupta S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11):1274–1283. doi: 10.1038/ng.2797.
   PubMed Web of Science ®Google Scholar
• Tuteja S, Qu L, Vujkovic M, et al. Genetic variants associated with plasma lipids are associated with the lipid response to niacin. J Am Heart Assoc. 2018;7(19):e03488. doi: 10.1161/JAHA.117.008461.
   PubMed Web of Science ®Google Scholar
• Linsel-Nitschke P, Heeren J, Aherrahrou Z, et al. Genetic variation at chromosome 1p13. 3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis. 2010;208(1):183–189. doi: 10.1016/j.atherosclerosis.2009.06.034.
   PubMed Web of Science ®Google Scholar
• Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature. 2010;466(7307):714–719. doi: 10.1038/nature09266.
   PubMed Web of Science ®Google Scholar
• Kjolby M, Nielsen MS, Petersen CM. Sortilin, encoded by the cardiovascular risk gene SORT1, and its suggested functions in cardiovascular disease. Curr Atheroscler Rep. 2015;17(4):496. doi: 10.1007/s11883-015-0496-7.
   PubMed Web of Science ®Google Scholar
• Patel KM, Strong A, Tohyama J, et al. Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis. Circ Res. 2015;116(5):789–796. doi: 10.1161/CIRCRESAHA.116.305811.
   PubMed Web of Science ®Google Scholar
• Goettsch C, Hutcheson JD, Aikawa M, et al. Sortilin mediates vascular calcification via its recruitment into extracellular vesicles. J Clin Invest. 2016;126(4):1323–1336. doi: 10.1172/JCI80851.
   PubMed Web of Science ®Google Scholar
• Carlo AS, Nykjaer A, Willnow TE. Sorting receptor sortilin—a culprit in cardiovascular and neurological diseases. J Mol Med . 2014;92(9):905–911. doi: 10.1007/s00109-014-1152-3.
   PubMed Web of Science ®Google Scholar
• Mortensen MB, Kjolby M, Bentzon JF. Sortilin and atherosclerosis. Oncotargets. 2015;6(23):19352–19353. doi: 10.18632/oncotarget.5098.
   PubMedGoogle Scholar
• Coutinho MF, Bourbon M, Prata MJ, et al. Sortilin and the risk of cardiovascular disease. Rev Port Cardiol. 2013;32(10):793–799. doi: 10.1016/j.repc.2013.02.006.
   PubMedGoogle Scholar
• Møller PL, Rohde PD, Winther S, et al. Sortilin as a biomarker for cardiovascular disease revisited. Front Cardiovasc Med. 2021;8:652584. doi: 10.3389/fcvm.2021.652584.
   PubMed Web of Science ®Google Scholar
• Strong A, Rader DJ. Sortilin as a regulator of lipoprotein metabolism. Curr Atheroscler Rep. 2012; 14(3):211–218. doi: 10.1007/s11883-012-0248-x.
   PubMed Web of Science ®Google Scholar
• Gustafsen C, Kjolby M, Nyegaard M, et al. The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion. Cell Metab. 2014;19(2):310–318. doi: 10.1016/j.cmet.2013.12.006.
   PubMed Web of Science ®Google Scholar
• Schmidt V, Willnow TE. Protein sorting gone wrong–VPS10P domain receptors in cardiovascular and metabolic diseases. Atherosclerosis. 2016;245:194–199. doi: 10.1016/j.atherosclerosis.2015.11.027.
   PubMed Web of Science ®Google Scholar
• Vega GL, Ma PT, Cater NB, et al. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome. Am J Cardiol. 2003;91(8):956–960. doi: 10.1016/s0002-9149(03)00111-5.
   PubMed Web of Science ®Google Scholar
• Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi: 10.3389/fimmu.2018.00754.
   PubMed Web of Science ®Google Scholar
• Westerterp M, Tall AR. SORTILIN: many headed hydra. Circ Res. 2015;116(5):764–766. doi: 10.1161/CIRCRESAHA.115.306036.
   PubMed Web of Science ®Google Scholar
• Sun S, Yang J, Xie W, et al. Complicated trafficking behaviors involved in paradoxical regulation of sortilin in lipid metabolism. J Cell Physiol. 2020;235(4):3258–3269. doi: 10.1002/jcp.29292.
   PubMed Web of Science ®Google Scholar
• Tall AR, Ai D. Sorting out sortilin. Circ Res. 2011;108(2):158–160. doi: 10.1161/RES.0b013e31820d7daa.
   PubMed Web of Science ®Google Scholar
• Avvisato R, Jankauskas SS, Varzideh F, et al. Sortilin and hypertension. Curr Opin Nephrol Hypertens. 2023;32(2):134–140. doi: 10.1097/MNH.0000000000000866.
   PubMed Web of Science ®Google Scholar
• Chu X, Liu R, Li C, et al. The association of plasma sortilin with essential hypertension and subclinical carotid atherosclerosis: a cross-sectional study. Front Cardiovasc Med. 2022; 9:966890. doi: 10.3389/fcvm.2022.966890.
   PubMed Web of Science ®Google Scholar
• Pietro PD, Oliveti M, Sommella E, et al. Sortilin evokes endothelial dysfunction and arterial hypertension through the dysregulation of sphingolipid metabolism and oxidative stress. Eur Heart J. 2020;41(Supplement_2):ehaa946.2704. doi: 10.1093/ehjci/ehaa946.2704.
   Google Scholar
• Varzideh F, Jankauskas SS, Kansakar U, et al. Sortilin drives hypertension by modulating sphingolipid/ceramide homeostasis and by triggering oxidative stress. J Clin Invest. 2022; 132(3):e156624. doi: 10.1172/JCI156624.
   PubMed Web of Science ®Google Scholar
• Mortensen MB, Kjolby M, Gunnersen S, et al. Targeting sortilin in immune cells reduces proinflammatory cytokines and atherosclerosis. J Clin Invest. 2014;124(12):5317–5322. doi: 10.1172/JCI76002.
   PubMed Web of Science ®Google Scholar
• Krauss RM, Dreon DM. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin Nutr. 1995;62(2):478S–487S. doi: 10.1093/ajcn/62.2.478S.
   PubMed Web of Science ®Google Scholar
• Krauss RM. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol. 2005;25(11):2265–2272. doi: 10.1161/01.ATV.0000186365.73973.f0.
   PubMed Web of Science ®Google Scholar
• Rizzo M, Berneis K. Should we measure routinely the LDL peak particle size? Int J Cardiol. 2006;107(2):166–170. doi: 10.1016/j.ijcard.2005.02.035.
   PubMed Web of Science ®Google Scholar
• Ramirez A, Hu P. Low high-density lipoprotein and risk of myocardial infarction. Clin Med Insights Cardiol. 2015;9:113–117. doi: 10.4137/CMC.S26624. eCollection 2015.
   PubMedGoogle Scholar
• Hirano T, Ito Y, Yoshino G. Measurement of small dense low-density lipoprotein particles. J Atheroscler Thromb. 2005;12(2):67–72. doi: 10.5551/jat.12.67.
   PubMed Web of Science ®Google Scholar
• Koba S, Hirano T, Ito Y, et al. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis. 2006;189(1):206–214. doi: 10.1016/j.atherosclerosis.2005.12.002.
   PubMed Web of Science ®Google Scholar
• Hoogeveen RC, Gaubatz JW, Sun W, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014;34(5):1069–1077. doi: 10.1161/ATVBAHA.114.303284.
   PubMed Web of Science ®Google Scholar
• Malhotra J, Tonorezos ES, Rozenberg M, et al. Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia. J Lipid Res. 2012;53(12):2747–2754. doi: 10.1194/jlr.P029785.
   PubMed Web of Science ®Google Scholar
• Kanonidou C. Small dense low-density lipoprotein: analytical review. Clin Chim Acta. 2021;520:172–178. doi: 10.1016/j.cca.2021.06.012.
   PubMed Web of Science ®Google Scholar